Bacil Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Bacil Pharma has a total shareholder equity of ₹16.9M and total debt of ₹1.6M, which brings its debt-to-equity ratio to 9.7%. Its total assets and total liabilities are ₹18.6M and ₹1.7M respectively.
Key information
9.7%
Debt to equity ratio
₹1.64m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹1.18m |
| Equity | ₹16.89m |
| Total liabilities | ₹1.72m |
| Total assets | ₹18.62m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524516's short term assets (₹1.5M) do not cover its short term liabilities (₹1.7M).
Long Term Liabilities: 524516 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 524516's net debt to equity ratio (2.7%) is considered satisfactory.
Reducing Debt: 524516's debt to equity ratio has increased from 5.8% to 9.7% over the past 5 years.
Debt Coverage: 524516's debt is not well covered by operating cash flow (2.8%).
Interest Coverage: Insufficient data to determine if 524516's interest payments on its debt are well covered by EBIT.